Pencil Biosciences has ambitious plans to develop a truly innovative gene modulation technology that could have impacts across a range of applications, including new therapeutic options for patients with rare diseases
Location: United Kingdom, England, Monks Heath
Total raised: $6.83M
Investors 3
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| 02.11.2023 | Syndicate ... | syndicater... |
| 09.02.2024 | Martlet | martletcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.09.2023 | - | $6.83M | - |
Mentions in press and media 1
| Date | Title | Description |
| 28.09.2023 | Pencil Biosciences raises £5.6M to advance gene editing for rare diseases | UK-based gene editing and modulation tech startup Pencil Biosciences has raised £5.6 million in Seed funding. Designed to assist the transformation of the gene editing landscape in therapeutic solutions for those with rare diseases and canc... |